Capillary Applied sciences India IPO Itemizing: Capillary Applied sciences India share value made a weak debut within the Indian inventory market as we speak, November 21. Capillary Applied sciences India share value was listed on Friday at ₹571.90 apiece on NSE, a reduction of 0.88% from its situation value of ₹577. In the meantime, on BSE, it listed at ₹560, down 2.95% from situation value.
The Capillary Applied sciences India IPO underperformed Avenue expectations, as seen from the gray market premium (GMP). The GMP for the IPO stood at ₹53 per share, which indicated a probable itemizing value of round ₹630 — translating to a premium of 9.19% over the higher finish of the problem value band.
Capillary Applied sciences India IPO Particulars
Capillary Applied sciences India made a weak debut on the BSE and NSE on November 21, 2025, after efficiently concluding its public situation. The IPO opened on November 14 and closed on November 18, with allotments finalised on November 19. The ₹877.70-crore IPO includes a recent issuance of 60 lakh shares amounting to ₹345 crore, together with a proposal on the market (OFS) of 92.3 lakh shares valued at ₹532.50 crore.
In line with the DRHP that was refiled in June 2025, the corporate had earlier proposed a ₹430-crore recent situation and an OFS of 1.83 crore shares. SEBI granted approval for the revised draft provide doc in September 2025.
The IPO lot dimension is mounted at 25 shares. For retail traders, the minimal funding is one lot. On the higher finish of the worth band, ₹577, the minimal funding required quantities to ₹14,425. Retail traders can apply for a most of 13 heaps, requiring an funding of ₹1,87,525.
The corporate intends to utilise the web proceeds from the recent situation for the next functions: (i) assembly cloud infrastructure bills, (ii) funding analysis, design and growth of its merchandise and platform, (iii) buying laptop methods mandatory for its operations, and (iv) supporting inorganic growth by way of unspecified acquisitions, together with common company functions.
JM Monetary, IIFL Capital Companies, and Nomura Monetary Advisory and Securities (India) Personal Restricted are serving because the book-running lead managers for the IPO, whereas MUFG Intime India Pvt. Ltd. is the registrar.
Capillary Applied sciences IPO was subscribed 52.98 occasions by the tip of Day 3. The retail portion was subscribed 15.85x, the NII portion was booked 69.85x, and the Certified Institutional Consumers (QIBs) section acquired 57.30x bids. The worker portion was subscribed 6.88x.
The corporate acquired bids for 44.39 crore shares towards 83.79 lakh shares on provide.
Individually, the corporate introduced on November 13 that it had secured ₹394 crore from anchor traders forward of the IPO launch.
About Capillary Applied sciences
Capillary Applied sciences operates as a software program product firm providing synthetic intelligence (AI)-driven, cloud-native software-as-a-service (SaaS) options, serving enterprise shoppers throughout international markets.
Headquartered in India, the corporate has an intensive worldwide footprint with workplaces in america, the UK, the United Arab Emirates, and a number of Asian international locations. As of March 31, 2025, Capillary catered to greater than 390 manufacturers in over 45 international locations.
In Fiscal 2025, the corporate reported a 13.93% rise in income from operations, growing to ₹598.26 crore from ₹525.10 crore in fiscal 2024, pushed by larger retainership earnings and different service revenues. Capillary additionally returned to profitability in fiscal 2025, posting a revenue of ₹13.28 crore, in comparison with a lack of ₹59.38 crore in fiscal 2024.
